Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
<p>Abstract</p> <p>Background</p> <p>The aim of this study is to compare the effectiveness of <sup>131</sup>I therapy between three groups of DTC patients who received 30, 60 or 100 mCi for thyroid remnant ablation after total thyroidectomy and were postoper...
Main Authors: | Kukulska Aleksandra, Krajewska Jolanta, Gawkowska-Suwińska Marzena, Puch Zbigniew, Paliczka-Cieslik Ewa, Roskosz Jozef, Handkiewicz-Junak Daria, Jarzab Michał, Gubała Elzbieta, Jarzab Barbara |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | Thyroid Research |
Online Access: | http://www.thyroidresearchjournal.com/content/3/1/9 |
Similar Items
-
Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes
by: Aleksandra Kukulska, et al.
Published: (2020-08-01) -
13-<it>cis</it>-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study
by: Handkiewicz-Junak Daria, et al.
Published: (2009-08-01) -
The role of postoperative adjuvant radiotherapy in local recurrence risk in medullary thyroid carcinoma
by: Aleksandra Kukulska, et al.
Published: (2019-12-01) -
Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone
by: G.J. Paz-Filho, et al.
Published: (2007-12-01) -
Lobo-isthmectomy in the management of differentiated thyroid cancer
by: Jolanta Krajewska, et al.
Published: (2023-02-01)